109 filings
8-K
MTNB
Matinas Biopharma Holdings Inc
9 May 24
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
4:06pm
8-K
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
28 Mar 24
Regulation FD Disclosure
9:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
27 Mar 24
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
4:22pm
8-K
MTNB
Matinas Biopharma Holdings Inc
25 Mar 24
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
8:05am
8-K
zvvvq q4je
22 Mar 24
Regulation FD Disclosure
9:20am
8-K
4cfzip2oof2i
22 Mar 24
Other Events
6:35am
8-K
7yvkikihsh940nkj2r05
26 Feb 24
Regulation FD Disclosure
8:05am
8-K
bgak9n74ozwn48s7un1
20 Feb 24
Regulation FD Disclosure
7:35am
8-K
wriron p6h77
9 Jan 24
Regulation FD Disclosure
7:30am
8-K
mxyncibovwiq easx
27 Dec 23
In an acute psoriasis model, data show reductions in tissue IL-17A mRNA and improvement in clinical disease markers including skin lesions
7:40am
8-K
cs9lk8 4eib
21 Dec 23
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
7:40am
8-K
yyyvnu28 9p
20 Nov 23
Regulation FD Disclosure
7:30am
8-K
irsugb0ml
9 Nov 23
Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docetaxel Formulation in a Melanoma Model
5:25pm
8-K
2kivt8vr gxkss1sk
8 Nov 23
Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
3rdw132 fgo51ueuodz
2 Nov 23
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
sul9pqybhkrzts0q63
22 Sep 23
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
5:25pm
8-K
i2fzs
20 Sep 23
Regulation FD Disclosure
7:30am
8-K
gy0c27phqw78d c55
9 Aug 23
Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
6b119ue ct51a6tap6sw
10 May 23
Results of Operations and Financial Condition
4:05pm